REICH, K.; PAPP, K.; BLAUVELT, A.; LANGLEY, R.; ARMSTRONG, A.; WARREN, R.; GORDON, K.; MEROLA, J.; MADDEN, C.; WANG, M.; VANVOORDEN, V.; LEBWOHL, M. Efficacy and Safety of Bimekizumab in Patients with Moderate to Severe Plaque Psoriasis: Results from BE VIVID, a 52-Week Phase 3, Randomized, Double-Blinded, Ustekinumab- and Placebo-Controlled Study. SKIN The Journal of Cutaneous Medicine, v. 4, n. 6, p. s82, 27 Oct. 2020.